arrow
G

Gen-Hong Di

fudan university shanghai cancer center
H指数:42
被引数:5,304

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study

早期三阴性乳腺癌患者 (新网球) 的新辅助蒽环类药物联合toripalimab和nab紫杉醇: 一项单臂II期研究

2024-08-012
OAAI
Updated data from FUTURE-C-PLUS: Combination of famitinib with camrelizumab plus nab-paclitaxel as first-line treatment for advanced, immunomodulatory triple-negative breast cancer, an open-label, single-arm, phase 2 trial
2022-02-150
PRE
Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing
2020-11-1054
OAAI